Freemelt, a leader in metal additive manufacturing, recently announced two significant orders for its Electron Beam Powder Bed Fusion (E-PBF) technology. Specifically, these orders mark a notable expansion of the company’s commercial footprint. Therefore, Freemelt is poised to enhance its impact in the additive manufacturing landscape.
Industrial Client Initiates Feasibility Study: Consequently, Validation of Novel Alloys
An innovative industrial client in North America, known for its advancements in additive manufacturing and novel alloy development, placed the first order. Moreover, this client aims to utilize Freemelt’s eMELT machine for a feasibility study. Indeed, they seek to validate the manufacturing of specialized high-temperature alloys. Furthermore, Freemelt CEO Daniel Gidlund emphasized the importance of these studies. In particular, they bridge the gap between concept and serial production. Thus, successful studies could lead to more eMELT orders.
Orthopaedic Implant OEM Order: Undeniably, A Milestone Achievement
The second order came from an orthopaedic implant OEM, aiming to complete a proof-of-concept for eMELT’s serial production capabilities. Additionally, Freemelt views this as a major milestone, reflecting years of collaboration. In fact, this order adds the first orthopaedic implant OEM to Freemelt’s customer roster. Consequently, the OEM’s evaluation of Freemelt’s E-PBF technology signifies their commitment to innovation in the medical sector. As a result, Freemelt is expanding its medical field presence.
Conclusion: Ultimately, Advancing Metal Additive Manufacturing
With these two orders, Freemelt is set to enhance its impact in high-temperature applications and the medical field. Ultimately, the company’s focus on feasibility studies and industrial collaboration drives metal additive manufacturing advancement.
Leave a Reply
You must be logged in to post a comment.